Chicos FAS Inc (CHS) Stock Fundamental Analysis
USA - NYSE:CHS - US1686151028 - Common Stock
7.59 USD
-0.01 (-0.13%)
7.591 USD
+0 (+0.01%)
Overall CHS gets a fundamental rating of 5 out of 10. We evaluated CHS against 119 industry peers in the Specialty Retail industry. CHS has an average financial health and profitability rating. CHS has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CHS was profitable.
CHS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CHS reported negative net income in multiple years.
CHS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
CHS's Return On Assets of 8.82% is fine compared to the rest of the industry. CHS outperforms 79.84% of its industry peers.
CHS has a better Return On Equity (26.40%) than 79.84% of its industry peers.
With a decent Return On Invested Capital value of 12.31%, CHS is doing good in the industry, outperforming 77.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.82% | ||
| ROE | 26.4% | ||
| ROIC | 12.31% |
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CHS has a better Profit Margin (5.29%) than 72.87% of its industry peers.
In the last couple of years the Profit Margin of CHS has grown nicely.
CHS has a better Operating Margin (6.16%) than 68.22% of its industry peers.
In the last couple of years the Operating Margin of CHS has grown nicely.
The Gross Margin of CHS (38.94%) is comparable to the rest of the industry.
CHS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.16% | ||
| PM (TTM) | 5.29% | ||
| GM | 38.94% |
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHS is creating some value.
Compared to 1 year ago, CHS has more shares outstanding
The number of shares outstanding for CHS has been reduced compared to 5 years ago.
The debt/assets ratio for CHS has been reduced compared to a year ago.
2.2 Solvency
CHS has an Altman-Z score of 3.22. This indicates that CHS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.22, CHS is in the better half of the industry, outperforming 70.54% of the companies in the same industry.
The Debt to FCF ratio of CHS is 0.42, which is an excellent value as it means it would take CHS, only 0.42 years of fcf income to pay off all of its debts.
CHS has a better Debt to FCF ratio (0.42) than 82.17% of its industry peers.
CHS has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
CHS has a Debt to Equity ratio of 0.06. This is in the better half of the industry: CHS outperforms 75.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.42 | ||
| Altman-Z | 3.22 |
ROIC/WACC1.34
WACC9.19%
2.3 Liquidity
CHS has a Current Ratio of 1.20. This is a normal value and indicates that CHS is financially healthy and should not expect problems in meeting its short term obligations.
CHS has a Current ratio of 1.20. This is in the lower half of the industry: CHS underperforms 72.09% of its industry peers.
A Quick Ratio of 0.42 indicates that CHS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.42, CHS is doing worse than 60.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.42 |
3. Growth
3.1 Past
The earnings per share for CHS have decreased strongly by -15.38% in the last year.
The Earnings Per Share has been growing slightly by 4.10% on average over the past years.
The Revenue has decreased by -0.24% in the past year.
The Revenue has been decreasing by -1.26% on average over the past years.
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%
3.2 Future
The Earnings Per Share is expected to decrease by -8.47% on average over the next years.
CHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.60% yearly.
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 9.86, the valuation of CHS can be described as very reasonable.
Based on the Price/Earnings ratio, CHS is valued a bit cheaper than the industry average as 79.07% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.42. CHS is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 10.29, the valuation of CHS can be described as very reasonable.
74.42% of the companies in the same industry are more expensive than CHS, based on the Price/Forward Earnings ratio.
CHS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.86 | ||
| Fwd PE | 10.29 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CHS is valued cheaper than 85.27% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CHS is valued a bit cheaper than 67.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.37 | ||
| EV/EBITDA | 4.72 |
4.3 Compensation for Growth
CHS has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as CHS's earnings are expected to decrease with -8.47% in the coming years.
PEG (NY)N/A
PEG (5Y)2.41
EPS Next 2Y-8.47%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for CHS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.59
-0.01 (-0.13%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners0.13%
Inst Owner Change0%
Ins Owners3.85%
Ins Owner Change0%
Market Cap937.06M
Analysts46.67
Price Target7.75 (2.11%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.66%
Min EPS beat(2)2.68%
Max EPS beat(2)14.64%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.59%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-2.44%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-2.73%
Max Revenue beat(4)1.35%
Revenue beat(8)4
Avg Revenue beat(8)0.55%
Revenue beat(12)7
Avg Revenue beat(12)2.48%
Revenue beat(16)7
Avg Revenue beat(16)-0.31%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.86 | ||
| Fwd PE | 10.29 | ||
| P/S | 0.44 | ||
| P/FCF | 16.37 | ||
| P/OCF | 8.25 | ||
| P/B | 2.22 | ||
| P/tB | 2.34 | ||
| EV/EBITDA | 4.72 |
EPS(TTM)0.77
EY10.14%
EPS(NY)0.74
Fwd EY9.71%
FCF(TTM)0.46
FCFY6.11%
OCF(TTM)0.92
OCFY12.11%
SpS17.08
BVpS3.42
TBVpS3.25
PEG (NY)N/A
PEG (5Y)2.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.82% | ||
| ROE | 26.4% | ||
| ROCE | 15.79% | ||
| ROIC | 12.31% | ||
| ROICexc | 14.55% | ||
| ROICexgc | 15.01% | ||
| OM | 6.16% | ||
| PM (TTM) | 5.29% | ||
| GM | 38.94% | ||
| FCFM | 2.71% |
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-2.56%
ROICexc growth 3YN/A
ROICexc growth 5Y1.76%
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
F-Score5
Asset Turnover1.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.42 | ||
| Debt/EBITDA | 0.14 | ||
| Cap/Depr | 134.65% | ||
| Cap/Sales | 2.67% | ||
| Interest Coverage | 35.98 | ||
| Cash Conversion | 66.14% | ||
| Profit Quality | 51.32% | ||
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.42 | ||
| Altman-Z | 3.22 |
F-Score5
WACC9.19%
ROIC/WACC1.34
Cap/Depr(3y)46.44%
Cap/Depr(5y)47.4%
Cap/Sales(3y)1.18%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.35%
EBIT growth 3YN/A
EBIT growth 5Y0.3%
EBIT Next Year18.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.25%
FCF growth 3YN/A
FCF growth 5Y0.2%
OCF growth 1Y108.67%
OCF growth 3Y69.3%
OCF growth 5Y-0.64%